HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transcutaneous applications for vaccination and immunotherapy].

Abstract
Although Edward Jenner applied the first vaccines by scratching cow pox material into the skin, the profound immunological properties of the skin have become evident through research and discoveries only in the last 20 years. The immunological cells in the epidermis and the dermis are suitable targets for transcutaneous vaccination and immunotherapy. However, as the skin represents a natural barrier for topically administered large molecules, novel methods to overcome this barrier function have been described. There are chemical, biochemical and physical methods, many of which are pain-free and therefore especially suitable for children. Also for adults non-invasive methods of vaccination and immunotherapy are attractive as self-administration is feasible. Future products are currently undergoing clinical tests which provide promising results.
AuthorsIsabel Krämer, Franziska Zabel, Thomas M Kündig, Pål Johansen
JournalPraxis (Praxis (Bern 1994)) Vol. 103 Issue 21 Pg. 1247-55 (Oct 15 2014) ISSN: 1661-8157 [Print] Switzerland
Vernacular TitleTranskutane Applikationen bei Impfungen und Immuntherapien.
PMID25305116 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Vaccines
Topics
  • Administration, Cutaneous
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy (methods)
  • Vaccines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: